370 related articles for article (PubMed ID: 15982204)
21. [Cutaneous cryptococcosis in AIDS patient].
Gasiorowski J; Szybejko-Machaj G; Machaj A
Pol Merkur Lekarski; 2001 Jun; 10(60):456-9. PubMed ID: 11503263
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous colesional acquired immunodeficiency syndrome associated Kaposi sarcoma and cryptococcosis.
Ramdial PK; Sing Y; Subrayan S; Calonje E
Am J Dermatopathol; 2010 Dec; 32(8):780-6. PubMed ID: 20802305
[TBL] [Abstract][Full Text] [Related]
23. Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates.
Tintelnot K; Lemmer K; Losert H; Schär G; Polak A
Mycoses; 2004 Dec; 47(11-12):455-64. PubMed ID: 15601449
[TBL] [Abstract][Full Text] [Related]
24. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
[No Abstract] [Full Text] [Related]
25. Disseminated, histologically confirmed Cryptococcus spp infection in a domestic ferret.
Eshar D; Mayer J; Parry NM; Williams-Fritze MJ; Bradway DS
J Am Vet Med Assoc; 2010 Apr; 236(7):770-4. PubMed ID: 20367045
[TBL] [Abstract][Full Text] [Related]
26. [Cryptococcal whitlow in a HIV positive patient].
Verneuil L; Dompmartin A; Duhamel C; Cren P; Six M; Le Maitre M; Galateau F; Moreau A; Leroy D
Ann Dermatol Venereol; 1995; 122(10):688-91. PubMed ID: 8687055
[TBL] [Abstract][Full Text] [Related]
27. Cryptococcus neoformans vertebral osteomyelitis.
Gurevitz O; Goldschmied-Reuven A; Block C; Kopolovic J; Farfel Z; Hassin D
J Med Vet Mycol; 1994; 32(4):315-8. PubMed ID: 7983576
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous cryptococcosis in an immunocompetent host: case report and review of the literature.
Revenga F; Paricio JF; Merino FJ; Nebreda T; Ramírez T; Martínez AM
Dermatology; 2002; 204(2):145-9. PubMed ID: 11937743
[TBL] [Abstract][Full Text] [Related]
29. Cryptococcal granulomas in an immunocompromised HIV-negative patient.
Taneja J; Bhargava A; Loomba P; Dogra V; Thakur A; Mishra B
Indian J Pathol Microbiol; 2008; 51(4):553-5. PubMed ID: 19008595
[TBL] [Abstract][Full Text] [Related]
30. A case of prosthetic valve endocarditis caused by Cryptococcus neoformans var. neoformans.
Banerjee U; Gupta K; Venugopal P
J Med Vet Mycol; 1997; 35(2):139-41. PubMed ID: 9147274
[TBL] [Abstract][Full Text] [Related]
31. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
32. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.
Perkins A; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
J Antimicrob Chemother; 2005 Dec; 56(6):1144-7. PubMed ID: 16282208
[TBL] [Abstract][Full Text] [Related]
33. Case report. Cutaneous cryptococcosis in a patient with systemic erythematous lupus.
Ramos L; López C; Gómez C; Mathurín S; Mateo A
Mycoses; 2001 Nov; 44(9-10):419-21. PubMed ID: 11766110
[TBL] [Abstract][Full Text] [Related]
34. Cryptococcosis in Colombia: results of the national surveillance program for the years 2006-2010.
Escandón P; de Bedout C; Lizarazo J; Agudelo CI; Tobón A; Bello S; Restrepo A; Castañeda E;
Biomedica; 2012 Sep; 32(3):386-98. PubMed ID: 23715187
[TBL] [Abstract][Full Text] [Related]
35. Localized Cutaneous Cryptococcosis: Summary of Reported Cases in Japan.
Noguchi H; Hiruma M; Maruo K; Jono M; Miyata K; Tanaka H; Tanabe K; Miyazaki Y; Ihn H
Med Mycol J; 2016; 57(3):E35-9. PubMed ID: 27581773
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.
Viviani MA; Cogliati M; Esposto MC; Lemmer K; Tintelnot K; Colom Valiente MF; Swinne D; Velegraki A; Velho R;
FEMS Yeast Res; 2006 Jun; 6(4):614-9. PubMed ID: 16696657
[TBL] [Abstract][Full Text] [Related]
37. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
38. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
Khyriem AB; Sujatha S; Parija SC
Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
[TBL] [Abstract][Full Text] [Related]
39. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
Abdel-Salam HA
Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
[TBL] [Abstract][Full Text] [Related]
40. Cryptococcosis.
Negroni R
Clin Dermatol; 2012; 30(6):599-609. PubMed ID: 23068147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
